Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open-Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers.
- DOI
- 10.1002/cpdd.1409
- Published
- 2024 Aug
- Container
- Clinical pharmacology in drug development
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cpdd.1409,
title = {Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open-Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers.},
author = {Leong CW and Yee KM and Liew I and Khaleb NA and Ahmad S and Rani TA and Lau KJ and Yunaidi DA and Simanjuntak R and Ginanjar VA},
year = {2024},
journal = {Clinical pharmacology in drug development},
doi = {10.1002/cpdd.1409},
url = {https://doi.org/10.1002/cpdd.1409}
}RIS
TY - JOUR TI - Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open-Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers. AU - Leong CW AU - Yee KM AU - Liew I AU - Khaleb NA AU - Ahmad S AU - Rani TA AU - Lau KJ AU - Yunaidi DA AU - Simanjuntak R AU - Ginanjar VA PY - 2024 JO - Clinical pharmacology in drug development DO - 10.1002/cpdd.1409 UR - https://doi.org/10.1002/cpdd.1409 ER -
APA
CW, L., KM, Y., I, L., NA, K., S, A., TA, R., KJ, L., DA, Y., R, S., & VA, G. (2024). Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open-Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers.. Clinical pharmacology in drug development. https://doi.org/10.1002/cpdd.1409
Source records
- pubmed · retrieved 2026-09-26T23:30:03.390Z